Background Image
Previous Page  93 / 102 Next Page
Information
Show Menu
Previous Page 93 / 102 Next Page
Page Background

L

ocal

management

with

methotrexate

of

cesarean

scar

ectopic

pregnancy

with

live

embryo

guided

by

transvaginal

ultrasound

: A

case

report

R

ev

A

ssoc

M

ed

B

ras

2016; 62(2):184-187

187

peated when

β

-hCG reaches a negative value or after 3

months of drug treatment. This should only be brought

forward if there are new episodes of bleeding.

In our case, a surgical approach was not required,

using merely drug treatment with a local dose plus three

local doses of systemic methotrexate. However, a slow re-

gression of

β

-hCG values was observed to the initially

high values, taking 58 days to reach negative values. An

Australian article about 13 cases of cesarean scar ecto-

pic pregnancy suggests that the association of local drug

treatment with systemic doses can reduce the time in-

terval for

β

-hCG to become negative and that local meth-

otrexate seems to be more effective than systemic treat-

ment alone due to the presence of fibrotic tissue in the

region of the scar, limiting the access of systemic medi-

cation.

14

After 3 to 6 months of disappearance of the image of

the ectopic pregnancy, our recommendation is to per-

form hysterosalpingography and hysteroscopy for better

assessment of the uterine cavity, as well as adequate re-

productive planning for these patients.

C

onclusion

The early diagnosis of cesarean scar ectopic pregnancy is

performed via transvaginal ultrasound and is fundamen-

tal for the indication of suitable conservative treatment.

Drug treatment with a local dose of ultrasound-guided

methotrexate in the presence of a live embryo, associat-

ed with a protocol of multiple doses of systemic metho-

trexate when

β

-hCG exceeds 5,000 mIU/mL has been

found effective, preventing mutilating surgeries and spar-

ing fertility in these patients.

R

esumo

Tratamento local com metotrexato guiado por ultrasso-

nografia transvaginal de gravidez ectópica em cicatriz de

cesárea com embrião vivo: relato de caso

A gravidez ectópica na cicatriz de cesárea é uma forma rara

de gestação ectópica com elevada morbimortalidade. O em-

prego de condutas conservadoras, como o tratamento me-

dicamentoso commetotrexato, tem evitado cirurgias muti-

ladoras, como a histerectomia, e preservado o futuro

reprodutivo da mulher. Relatamos um caso de paciente de

30 anos, com gravidez ectópica em cicatriz de cesárea, com

embrião vivo, tratada com injeção local de metotrexato guia-

da por ultrassonografia transvaginal, complementada com

tratamento sistêmico commúltiplas doses de metotrexato.

Palavras-chave:

gravidez ectópica, metotrexato, cicatriz,

cesárea.

R

eferences

1.

Fylstra DL, Pound-Chang T, Miller MG, Cooper A, Miler KM. Ectopic

pregnancy within a cesarean delivery scar: a case report. Am J Obstet Gynecol.

2002; 187(2):302-4.

2.

Jourdain O, Fontanges M, Schiano A, Rauch F, Gonnet JM. [Management

of other ectopic pregnancies (corneal, interstitial, angular, ovarian)]. J Gynecol

Obstet Biol Reprod (Paris). 2003; 32(7 Suppl):S93-100.

3. Bignardi T, Condous G. Transrectal ultrasound-guided surgical evacuation of

cesarean scar ectopic pregnancy. UltrasoundObstet Gynecol. 2010; 35(4):481-5.

4.

Jurkovic D, Hillaby K, Woelfer B, Lawrence A, Salim R, Elson CJ. First-

trimester diagnosis and management of pregnancies implanted into the

lower uterine segment Cesarean section scar. Ultrassond Obst Gynecol.

2003; 21(3):220-7.

5. SeawKM,HuangLW,linYH,LinMY,TsaiYL,HwangJL.Cesareanscarpregnancy:

issues inmanagement. UltrassoundObstet Gynecol. 2004; 23(3):247-53.

6.

Herman A, Weinraub Z, Avrech O, Maymon R, Ron-El R, Bukovsky Y. Follow

up and outcome of isthmic pregnancy located in a previous caesarean section

scar. Br J Obstet Gynaecol. 1995; 102(10):839-41.

7. Vial Y, Petignat P, Hohlfeld P. Pregnancy in a cesarean scar. Ultrasound

Obstet Gynecol. 2000; 16(6):592-3.

8. Rotas MA, Haberman S, Levgur M. Cesarean scar ectopic pregnancies: etiology,

diagnosis, and management. Obstet Gynecol. 2006; 107(6):1373-81.

9. Larsen JV, SolomonMH. Pregnancy in a uterine scar sacculus – an unusual cause

of postabortal haemorrhage. A case report. S Afr Med J. 1978; 53(4):142-3.

10. Timor-Tritsch IE, Monteagudo A. Unforeseen consequences of the increasing

rate of cesarean deliveries: early placenta accreta and cesarean scar pregnancy.

A review. Am J Obstet Gynecol. 2012; 207(1):14-29.

11. Agarwal N, Shahid A, Odejinmi F. Caesarean scar pregnancy (CSP): a rare

case of complete scar dehiscence due to scar ectopic pregnancy and its

management. Arch Gynecol Obstet. 2013; 288(1):231-2.

12. Ash A, Smith A, Maxwell D. Caesarean scar pregnancy. BJOG. 2007;

114(3):253-63.

13.

Fylstra DL. Ectopic pregnancy within a cesarean scar: a review. Obst Gynecol

Surv. 2002; 57(8):537-43.

14.

Michener C, Dickinson JE. Caesarean scar ectopic pregnancy: a single centre

case series. Aust N Z J Obstet Gynaecol. 2009; 49(5):451-5.

15.

Elito J, Araujo E, Santana EFM, Szejnfeld D, Helfer TM, Nardozza LMM, et

al. Uterine artery embolization with methotrexate infusion as treatment for

cesarean scar pregnancy. Med Ultrason. 2013; 15(3):240-3.

FIGURE 3

 Transvaginal ultrasonography after 3 months of drug

treatment with local and systemic methotrexate for cesarean scar

ectopic pregnancy.